Yuan-Ji Day,Li-Man Hung,Shiang-Suo Huang,Hsiang-Ruei Liao,Chiou-Mei Lee,Jiin-Tarng Liou,Fu-Chao Liu,Chih-Chieh Mao,Polung Yang
申请号：
US14837926
公开号：
US20150366912A1
申请日:
2015.08.27
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Preactivated and disaggregated shape-changed platelets, fixed shape-changed platelets, and a pharmaceutical composition thereof are used for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108. Activated platelets release and transfer adhesion factors to the surface of platelet cells, and trap stromal vascularity inflammatory cells from inflammated and damaged place, and the stromal vascularity inflammatory cells are eliminated through the circulatory system to alleviate inflammation. The fixed shape-changed platelets are able to alleviate inflammation and sustainable for longer storage duration.
